INTRODUCTIONSarcomas represent the rarest form of solid tumor malignancies, accounting for <1% of tumors in the adult population with over 50 recognized histologic types, and numerous subtypes. Some of the histologic types occur with a high frequency in the retroperitoneum where their varied histologic patterns can overlap, especially in the context of limited sampling, potentially leading to a diagnostic pitfall. The diagnosis of sarcoma can, at times, be notoriously challenging for pathologists, particularly those without subspecialty expertise. Definitive classification of a tumor often requires integration of clinical history and diagnostic imaging results, in addition to judicious application of ancillary techniques such as immunohistochemistry, cytogenetics and molecular pathology. The latter is particularly important in view of the emergence of personalized medicine based of molecularly targeted therapy. In this review, we highlight pertinent pathologic and molecular aspects of sarcomas common in the retroperitoneum, relevant to the surgical oncologist.WELL‐DIFFERENTIATED LIPOSARCOMADefinitionWell‐differentiated liposarcoma (WDLS) is a locally aggressive malignant mesenchymal neoplasm composed of mature adipose tissue with nuclear atypia in either or both stromal cells and adipocytes. Tumors are characterized by sheets of adipocytes with variability in size and shape, with hyperchromatic nuclei and/or broad cellular septae containing cells with enlarged and hyperchromatic nuclei;
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud